Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | Over 1,000Exact Company Size |
Primary Industry | 5417 Scientific Research & Development Services |
Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology |
Address | 675 West Kendall Street Cambridge, MA 02142 |
Alnylam Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $100 - $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Alnylam Pharmaceuticals P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
THE BRIDGE Education services in the medical field for medical professionals, patients and their families, namely, conducting live onsite seminars, providing on-demand, non-downloadable video classes, and providing one-on-one and family tutoring; educational services, namely, conducting live onsite seminars, providing on-demand non-downloadable video classes, and providing one-on-one and family tutoring, for training medical professionals and patients regarding amyloidosis, and distributing course materials in connection therewith | 03/30/2023 |
ELEVATE Maintaining a clinical registry database for patients with genetic mutations that cause enzyme defects and acute hepatic porphyria; maintaining a registry on the clinical outcomes of acute hepatic porphyria in patients over time | 04/23/2021 |
BONAPH1DE Maintaining a clinical registry database for patients with inherited disorders of the liver and primary hyperoxaluria; maintaining a registry on the clinical outcomes of primary hyperoxaluria in patients over time | 04/23/2021 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LEIDOS | Denver, CO | 100 |
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
INC RESEARCH | Raleigh, NC | 27 |
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
SYNEOS HEALTH | Raleigh, NC | 13 |
ILLUMINA | San Diego, CA | 12 |
UT-BATTELLE | Oak Ridge, TN | 11 |
PRA HOLDINGS | Raleigh, NC | 11 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
BROAD INSTITUTE | Cambridge, MA | 100 |
BEIGENE USA | Cambridge, MA | 69 |
ALNYLAM PHARMACEUTICALS | Cambridge, MA | 52 |
SAGE THERAPEUTICS | Cambridge, MA | 47 |
INTELLIA THERAPEUTICS | Cambridge, MA | 35 |
IPSEN BIOPHARMACEUTICALS | Cambridge, MA | 34 |
Company | Revenue ($ MM) |
---|---|
|